About the Event

Due to the COVID-19 pandemic, Australians have experienced firsthand how changes can be incorporated into our daily routines in a very short time. Initially, we came together with a common goal, to survive and manage the pandemic. We implemented the changes through necessity and valued each other’s input. The next step is to continue this collaboration by understanding that working together with a common purpose benefits all of us.

These changes are the results of three key actions:

A common purpose: Ensuring all are ‘on the same page’, brings a clear focus on what we are trying to achieve. If there are roadblocks to having a common purpose, we need to address and ensuring our policies, standards and guidance’s are fit for our purpose. This common purpose underpins our ability of working together for success.

Technology as an enabler: Accelerating the adoption of digitalisation is enabling major shifts in clinical trial design and operations, regulatory strategies and therapeutic area asset and portfolio management, just to mention a few. The pandemic has fast tracked this implementation it is already having an enormous impact on the utilisation of information.

Stakeholder inclusiveness: Including the voices of all stakeholders is starting to revolutionised the way we look at innovation. Patients, investigators, sponsors, manufactures and governments have a role in the development of innovative therapies. These voices ensure that otherwise silent issues are brought to the fore, ensuring our deliverables meet the needs of all our customers.

By embracing a common purpose, technology as an enabler and stakeholder inclusiveness, we can work together for success.

Brought to you by ARCS Australia. For more information and to register please click here.

---